Literature DB >> 2898792

Clinical profile of gepirone, a nonbenzodiazepine anxiolytic.

N E Harto, R J Branconnier, K F Spera, E C Dessain.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898792

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


× No keyword cloud information.
  7 in total

Review 1.  5-HT1A partial agonists. What is their future?

Authors:  D A Glitz; R Pohl
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

2.  Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone.

Authors:  R J Rodgers; J K Shepherd
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder.

Authors:  I M van Vliet; H G Westenberg; J A den Boer
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

4.  Evaluation of the dependence potential of the selective 5-H1A agonist ipsapirone in rats and of its effects on benzodiazepine withdrawal.

Authors:  A J Goudie; M J Leathley
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  TJS-010, a new prescription of oriental medicine, enhances 8-OH-DPAT-induced effects in rats.

Authors:  A Kagaya; A J Tanra; H Shinno; A Kugaya; M Muraoka; T Oyamada; Y Uchitomi; S Yamawaki
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

6.  Buspirone, gepirone, ipsapirone, and zalospirone have distinct effects on the differential-reinforcement-of-low-rate 72-s schedule when compared with 5-HTP and diazepam.

Authors:  J B Richards; K E Sabol; T H Hand; D C Jolly; G J Marek; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

Review 7.  Azapirones for generalized anxiety disorder.

Authors:  C A Chessick; M H Allen; Me Thase; A B C Batista Miralha da Cunha; F F K Kapczinski; M S M L de Lima; J J S S dos Santos Souza
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.